New immunology study highlights importance of COVID vaccination of those who have already been exposed to the virus
Study finds COVISHIELD, COVAXIN vaccines enhance immune responses in those with pre-existing SARS-CoV-2 immunity, mitigating vaccine hesitancy. Researchers from St John’s Research Institute led multi-centric study; funded by Hindustan Unilever. Results suggest persistent anti-COVID-19 immunity up to one year post COVISHIELD vaccination.
The Hindu ·